https://www.selleckchem.com/pr....oducts/alflutinib-as
Cure SMA maintains the largest patient-reported database for people affected with spinal muscular atrophy (SMA). In 2017, Cure SMA initiated annual surveys with their membership to collect demographic and disease characteristics, healthcare, and burden of disease information from patients and caregivers. To summarize results from two large-scale Cure SMA surveys in 2017 and 2018. Cure SMA database members were invited to complete surveys; these were completed by caregivers for living or deceased individuals with SMA
Curtir
Comentario
Compartilhar
